Motto of the day

Poisons and medicine are oftentimes the same substance given with different intents

Peter Mere Latham

obrazek winietyobrazek winiety

Scientific publications

Diverse immune mechanisms may contribute to the survival benefit seen in cancer patients receiving hyperthermia.

Publishing house: Immunologic Research
Main author: Elizabeth A. Repasky
Other authors: Adrienne J. Peer, Melissa J. Grimm, Evan R. Zynda
Date: 2009-09

DOI: 10.1007/sI2026-009-8115-8

Language: english

Publication class: Review article

Abstract: There is increasing documentation of significant survival benefits achieved in cancer patients treated with hyperthermia in combination with radiation and/or chemotherapy. Most evidence collected regarding the mechanisms by which hyperthermia positively influences tumor control has centred on in vitro data showing the ability of heat shock temperatures (usually above 42°C) to result in radio- or chemosensitization. However, these high temperatures are difficult to achieve in vivo, and new thermometry data in patients reveal that much of the tumor and surrounding region is only heated to 40-41°C or less as a result of vascular drainage from the target zone of the heated tumor. Thus, there is now a growing appreciation of a role for mild hyperthermia in the stimulation of various arms of the immune system in contributing to long term protection from tumor growth. Indeed, a review of recent literature suggests the existence of an array of thermally sensitive functions which may exist naturally to help the organism to establish a new "set point" of immune responsiveness during fever. This review summarizes recent literature identifying complex effects of temperature on immune cells and potential cellular mechanisms by which increased temperature may enhance immune surveillance.

Need more information about the article? Please contact with PTHO by email.